The Sentec suite of attachment options for transcutaneous CO2 monitoring allows care teams to confidently choose solutions that support the clinical priorities of each patient — across populations and care settings.

Learn more about how a level IV NICU team was recently successful in developing an all-encompassing strategy to drive consistent utilization of transcutaneous monitoring with the goal of improving patient care.

In NICUs, PICUs, and sleep labs around the world, transcutaneous monitoring has increasingly become a trusted tool for continuous, noninvasive CO2 measurement. The technology can help reduce the need for frequent blood draws, enable proactive ventilator management, and offer additional benefits as care teams support diverse patient populations.

Chronic hypercapnia, characterized by elevated levels of CO2, poses a significant challenge for individuals with conditions like chronic obstructive pulmonary disease (COPD), neuromuscular disorders (NMD), and obesity. Although the negative effects of chronic hypercapnia are widely acknowledged, researchers at the University of Michigan are shedding light on the true urgency of its management.

There is a long list of decisions to make when adopting new technology in a hospital unit, and transcutaneous monitoring is no exception. Some of the most overlooked decisions in our experience are those around mounting and storing the devices both during monitoring, while not in use, as well as for performing maintenance.